NUDT15 R139C Variants Increase the Risk of Azathioprine-Induced Leukopenia in Chinese Autoimmune Patients
Open Access
- 7 May 2018
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 9, 460
Abstract
The aim of this study was to investigate the influence of NUDT15 R139C, thiopurine S-methyltransferase (TPMT), and 6-TGN on azathioprine (AZA) induced leukopenia in Chinese autoimmune patients. Among 87 enrolled patients, 23 (26.4%) had leukopenia. The NUDT15 R139C variant was associated with leukopenia (p = 1.86 × 10−7; OR: 7.59; 95% CI: 3.16–18.21). However, TPMT genotype was not shown to be correlated with the incidence of leukopenia (p = 0.95). There was no significant difference of 6-TGN concentration between patients with or without leukopenia (p = 0.15) and no association was found in patients with NUDT15 R139C variants alleles (p = 0.62). Finally, we found that the range of 6-TGN concentrations in autoimmune diseases was much lower than the established 6-TGN monitoring range for inflammatory bowel diseases. Therefore, the variant of NUDT15 R139C is strongly associated with AZA-induced leukopenia in Chinese patients with various autoimmune diseases such as systemic lupus erythematosus, Sjögren's syndrome, etc.Keywords
This publication has 51 references indexed in Scilit:
- Lupus enteritis: from clinical findings to therapeutic managementOrphanet Journal of Rare Diseases, 2013
- Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 UpdateClinical Pharmacology & Therapeutics, 2013
- The potential influence of 5-aminosalicylic acid on the induction of myelotoxicity during thiopurine therapy in inflammatory bowel disease patientsEuropean Journal of Gastroenterology & Hepatology, 2012
- Thiopurine Methyltransferase Gene Polymorphisms in Chinese Patients with Inflammatory Bowel DiseaseDigestion, 2009
- Prospective evaluation of the pharmacogenetics of azathioprine in the treatment of inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2008
- Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphismLupus, 2008
- Thiopurine Treatment in Inflammatory Bowel DiseaseClinical Pharmacokinetics, 2007
- The frequency and distribution of thiopurine methyltransferase alleles in Caucasian and Asian populationsPharmacogenetics, 1999
- Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease1998
- 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity.Gut, 1996